陳 龍

Medicine & Life Sciences

1. Stroke 100%
2. Parkinson Disease 76%
3. Taiwan 43%
4. Tissue Plasminogen Activator 39%
5. Intracranial Hemorrhages 27%
6. Extracellular Vesicles 25%
7. Cohort Studies 24%
8. Cognitive Dysfunction 23%
9. Dementia 22%
10. Meta-Analysis 19%
11. Cerebral Hemorrhage 17%
12. Computer Neural Networks 16%
13. Mental Status and Dementia Tests 16%
14. Anticoagulants 15%
15. Induced Hypothermia 14%
16. Middle Cerebral Artery 14%
17. Cognition 14%
18. Synucleins 12%
19. Gait 12%
20. Prospective Studies 11%
21. Heart Arrest 11%
22. Confidence Intervals 11%
23. Homeostasis 10%
24. Amyloid 10%
25. Area Under Curve 10%
26. Epilepsy 10%
27. Transverse Sinuses 10%
28. Atrial Fibrillation 10%
29. Population 10%
30. Vertebral Artery 10%
31. Alzheimer Disease 9%
32. Machine Learning 9%
33. Internal Carotid Artery 9%
34. Mortality 9%
35. Safety 9%
36. Therapeutics 8%
37. Cholinesterase Inhibitors 8%
38. Infarction 8%
39. Motor Skills 8%
40. Arteries 8%
41. Intermediate Filaments 8%
42. Retrospective Studies 7%
43. Azepines 7%
44. Brain-Derived Neurotrophic Factor 7%
45. Glucose 7%
46. Cerebrovascular Disorders 7%
47. Histone Deacetylase Inhibitors 7%
48. Biomarkers 6%
49. Case-Control Studies 6%